Newsroom
The ADOPT Program: Paving the way for access & delivery
Earlier this year, the Consortium celebrated the official launch of its ADOPT1 Program – an implementation research program that paves the way for the large-scale delivery of the new pediatric medication to treat schistosomiasis in preschool-age children in endemic countries, once registered.
Nadia Ben Meriem, Senior Advisor at the SCI Foundation and co-lead of the Consortium ADOPT program, explains more in this short video interview.
1Adoption of Levo-Praziquantel 150mg for schistosomiasis by endemic countries